EWTX Edgewise Therapeutics Inc

$15.35

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About Edgewise Therapeutics Inc

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The company is headquartered in Boulder, Colorado.

Website: https://edgewisetx.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1710072
Address
3415 COLORADO AVE., BOULDER, CO, US
Valuation
Market Cap
$1.41B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
3.08
Performance
EPS
$-1.45
Dividend Yield
—
Profit Margin
0.00%
ROE
-34.40%
Technicals
50D MA
$22.35
200D MA
$25.18
52W High
$38.12
52W Low
$10.60
Fundamentals
Shares Outstanding
105M
Target Price
$42.78
Beta
0.33

EWTX EPS Estimates vs Actual

● Estimated
● Actual

EWTX News & Sentiment

Sep 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Wall Street Analysts Think Edgewise Therapeutics ( EWTX ) Could Surge 182%: Read This Before Placing a Bet
The mean of analysts' price targets for Edgewise Therapeutics (EWTX) points to an 182% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Sep 02, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Wall Street Analysts Believe Edgewise Therapeutics ( EWTX ) Could Rally 172.96%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 173% in Edgewise Therapeutics (EWTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Aug 25, 2025 • Benzinga BULLISH
Muscular Dystrophy Association Launches #MDAstrong Campaign in September During Historic 75th Anniversary, Kicking Off on Labor Day Weekend
New York, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- This September, the Muscular Dystrophy Association ( MDA ) is launching its milestone #MDAstrong campaign during a historic moment for the organization: its 75th anniversary.
Aug 14, 2025 • Benzinga NEUTRAL
Edgewise Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm - Edgewise Therapeutics ( NASDAQ:EWTX )
Investors can contact the law firm at no cost to learn more about recovering their losses
Jul 28, 2025 • Benzinga NEUTRAL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX - Edgewise Therapeutics ( NASDAQ:EWTX )
NEW YORK, July 28, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ( "Edgewise" or the "Company" ) EWTX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Jul 23, 2025 • Benzinga NEUTRAL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX - Edgewise Therapeutics ( NASDAQ:EWTX )
NEW YORK, July 23, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ( "Edgewise" or the "Company" ) EWTX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Sentiment Snapshot

Average Sentiment Score:

0.221
50 articles with scored sentiment

Overall Sentiment:

Bullish

EWTX Reported Earnings

Feb 20, 2025
Dec 31, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $-0.42
  • Estimate: $-0.42
  • Whisper: —
  • Surprise %: 0.5%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $-0.36
  • Estimate: $-0.37
  • Whisper: —
  • Surprise %: 2.7%
Aug 08, 2024
Jun 30, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.34
  • Whisper: —
  • Surprise %: 0.0%
May 09, 2024
Mar 31, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $-0.33
  • Estimate: $-0.39
  • Whisper: —
  • Surprise %: 15.4%
Feb 22, 2024
Dec 31, 2023 (Pre market)
-0.04 Surprise
  • Reported EPS: $-0.47
  • Estimate: $-0.43
  • Whisper: —
  • Surprise %: -9.3%
Nov 09, 2023
Sep 30, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $-0.41
  • Estimate: $-0.40
  • Whisper: —
  • Surprise %: -2.5%
Aug 10, 2023
Jun 30, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.40
  • Whisper: —
  • Surprise %: 15.0%
May 11, 2023
Mar 31, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $-0.36
  • Estimate: $-0.36
  • Whisper: —
  • Surprise %: 0.0%
Feb 23, 2023
Dec 31, 2022 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.31
  • Estimate: $-0.34
  • Whisper: —
  • Surprise %: 8.8%

Financials